EUVIMEDEUVIMED entdecken
Open Access

Sexual dysfunction in selective serotonin reuptake inhibitors (SSRIs) and potential solutions: A narrative literature review

Elizabeth Jing, Kristyn Straw-Wilson

Mental Health Clinician · 2016-07 · 6 (4) · 191-196

DOI: 10.9740/mhc.2016.07.191 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mental Health Clinician, 2016-07. Verfasst von Elizabeth Jing und 1 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral Candidate, Advance Pharmacy Practice Experience student at the Southern Arizona Veterans Affairs Health System, Tucson, Arizona, jing@pharma…. Die Arbeit wurde bisher 115-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sexual dysfunction is an underdiscussed adverse effect to selective serotonin reuptake inhibitors (SSRIs) and may increase the risk for discontinuation and nonadherence to antidepressant pharmacotherapy. Given the prevalence of depression, health care providers should educate patients about SSRI-associated sexual dysfunction in order to promote patient awareness and medication adherence. This study evaluated primary literature from 1997 to 2015 to identify SSRI-related sexual side effects, therapeutic alternatives, and treatment strategies. The results indicate that paroxetine is associated with the greatest rate of sexual dysfunction among the SSRIs. Potential alternatives to SSRI treatment include bupropion, mirtazapine, vilazodone, vortioxetine, and serotonin-norepinephrine reuptake inhibitors. In the event that a subject responds solely to SSRIs but experiences unwanted sexual side effects, bupropion may be added as an adjunctive medication. Some limited evidence also suggests that saffron may reduce some aspects of sexual dysfunction, excluding ability to reach orgasm.

Schlagwörter

Stichwörter der Autor:innen

SSRIbupropioncitalopramdelayed ejaculationescitalopramfluoxetinemirtazapineparoxetineselective serotonin reuptake inhibitorssertralinesexual dysfunctionsexual side effectvenlafaxine

Autor:innen und Institutionen

  • Doctoral Candidate, Advance Pharmacy Practice Experience student at the Southern Arizona Veterans Affairs Health System, Tucson, Arizona, jing@pharmacy.arizona.edu.
  • Psychiatric Pharmacist, Southern Arizona Veterans Affairs Health System, Tucson, Arizona.

Zitieren

APA

Jing, E., & Straw-Wilson, K. (2016). Sexual dysfunction in selective serotonin reuptake inhibitors (SSRIs) and potential solutions: A narrative literature review. Mental Health Clinician, 6(4), 191-196. https://doi.org/10.9740/mhc.2016.07.191

Vancouver

Jing E, Straw-Wilson K. Sexual dysfunction in selective serotonin reuptake inhibitors (SSRIs) and potential solutions: A narrative literature review. Mental Health Clinician. 2016;6(4):191-196. doi:10.9740/mhc.2016.07.191

BibTeX
@article{Jing2016,
  author = {Jing, Elizabeth and Straw-Wilson, Kristyn},
  title = {Sexual dysfunction in selective serotonin reuptake inhibitors (SSRIs) and potential solutions: A narrative literature review},
  journal = {Mental Health Clinician},
  year = {2016},
  volume = {6},
  number = {4},
  pages = {191--196},
  doi = {10.9740/mhc.2016.07.191}
}
Kostenlos starten →